Labshake search
Citations for R&D Systems :
1 - 50 of 4239 citations for Human Immunodeficiency Virus p24 Protein HIV 1 Clade B since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: Culture supernatants were diluted 20-fold with PBS + 1% BSA + 0.2% Triton X-100 then analyzed for HIV-p24 protein using the HIV-1 Gag p24 DuoSet ELISA Development System (R&D Systems) with the R&D TMB substrate reagent pack for detection ...
-
bioRxiv - Microbiology 2024Quote: Viral titers were determined using the HIV-1 Gag p24 DuoSet ELISA (R&D Systems). After seeding TZM-bl cells at 1 × 104 in flat-bottom 96-well plates (CELLTREAT) ...
-
bioRxiv - Immunology 2022Quote: ... and tubulin were detected by immunoblotting using HIV-1 gag p24 antibody (1:1000 dilution, MAB7360, mouse monoclonal, R&D systems, Minneapolis, MN), human CD207 antibody (1:1000 dilution ...
-
bioRxiv - Bioengineering 2023Quote: ... and p24-Gag protein (MAB7360-SP, R&D Systems) (2 µg/mL ...
-
HIV-1 Nef interacts with LMP7 to attenuate immunoproteasome formation and MHC-I antigen presentationbioRxiv - Microbiology 2019Quote: ... Virus titers were measured using p24 enzyme-linked immunosorbent assays (ELISA) (R&D Systems, MN, USA). CD4+ Jurkat T cells were incubated with NL4-3 or NL4-3dNef viruses at MOI ...
-
bioRxiv - Microbiology 2021Quote: ... Memory CD4+ T-cells were infected with HIV-1 (50 ng HIV-p24/106 cells) and then cultured in the presence of IL-2 (5 ng/ml; R&D Systems, Minneapolis, MN, USA) for up to 9 days ...
-
bioRxiv - Bioengineering 2023Quote: ... Fibroblasts were treated with or without recombinant human transforming growth factor beta 1 (TGF-β1) protein (240-B, R&D Systems) at 1.25 ng/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... Inhibitors used in the study are Recombinant Human TGF-β1 protein (R&D Systems, 240-B-002), SAHA (Sigma ...
-
bioRxiv - Cancer Biology 2023Quote: ... and for granzyme B using human Granzyme B DuoSet ELISA (R&D Systems). All ELISAs were performed as per manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2023Quote: Recombinant human TGFβ1 (240-B R&D Systems) was stocked as 20 μg/ml in DMSO and AZ3146 (SML-1427 Sigma Aldrich ...
-
bioRxiv - Neuroscience 2020Quote: ... Recombinant proteins were separately preincubated with neuronal cultures and recombinant tau protein for 3 hours prior to incubation of neuronal cultures with the mixer containing recombinant proteins (100nM Human LRP-1 Cluster IV Fc Chimera Protein; 10nM Human LRPAP Protein [R&D systems]). For pharmacological treatments ...
-
bioRxiv - Cancer Biology 2021Quote: ... and b) Goat anti-human CD4 (1:400, R&D Systems AF-379-NA) and Rabbit anti-human CD8 (1:400 ...
-
bioRxiv - Cancer Biology 2019Quote: ... goat anti-human Cathepsin B antibody (R&D systems AF953), goat anti human cathepsin-D antibody (Santa Cruz sc-6486) ...
-
bioRxiv - Biophysics 2022Quote: Human Apolipoprotein B Quantikine ELISA Kit (R&D Systems, DAPB00) was used according to manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2023Quote: ... recombinant human BMP4 (10 ng/ml; “B”; R&D Systems), and 100 nM retinoic acid (“Ra” ...
-
bioRxiv - Microbiology 2023Quote: ... or 1 μg of human recombinant Gas6 protein (R&D Systems) prior to K ...
-
bioRxiv - Microbiology 2022Quote: ... and one normalization antibody: mouse anti-p24 Gag (R&D Systems # MAB7360; 1:1000) or mouse anti-actin (Cell Signaling #8H10D10 ...
-
bioRxiv - Immunology 2022Quote: ... and then treated with 10 ng/mL of recombinant human TGF-b (R&D Systems; 240-B-002) or 10 ng/mL of recombinant human IL-1β (R&D Systems ...
-
bioRxiv - Immunology 2020Quote: ... or 100 U/mL human recombinant Ifn-b (R&D systems). Cells were harvested 18 hrs post-transfection ...
-
bioRxiv - Immunology 2020Quote: ... or 100 U/mL human recombinant Ifn-b (R&D systems) at the cell counts and conditions previously described for the cellular luciferase assays ...
-
bioRxiv - Immunology 2022Quote: ... either alone or in combination with 1 μg/ml mouse IgG2 B anti-human TIGIT (R&D systems) or 1 μg/ml goat IgG anti-human TIM-3 (R&D systems ...
-
bioRxiv - Molecular Biology 2021Quote: ... Recombinant human TGFβ1 (100-B-001) and Thrombospondin-1 (3074-TH-050) were purchased from R&D Systems. Matrigel-based hydrogel culture system were employed ...
-
Tuning trophoblast invasion in a gelatin hydrogel via soluble cues from the maternal-fetal interfacebioRxiv - Bioengineering 2020Quote: ... Recombinant human transforming growth factor β1 (TGFβ1; R&D Systems, 240-B) and recombinant human epidermal growth factor (EGF ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was purchased from R&D systems.
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was from R&D Systems (UK) and used at a final concentration of 0.5 ng/ml ...
-
bioRxiv - Cell Biology 2022Quote: ... 10 ng/mL human recombinant activin B (R&D Systems, Minneapolis, MN), 0.1 nmol/L exendin-4 (Sigma) ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant human DEL-1 protein (6046-ED) (R&D Systems, Minneapolis, MN, USA) and/or RGD peptide (A8052 ...
-
bioRxiv - Bioengineering 2024Quote: ... 1 ng/mL human bone morphogenetic protein 4 (Bmp4) (R&D Systems, Inc.), 20 ng/mL human basic fibroblast growth factor (b-FGF ...
-
bioRxiv - Bioengineering 2020Quote: ... 97 µL of urine was incubated with 1 µL of human cathepsin B (R&D Systems, 953-CY-010) and 1 µL of DTT for 15 minutes to inactivate the urine cysteine protease inhibitor ...
-
bioRxiv - Cell Biology 2023Quote: M.tb-Lux was exposed to control- or HIV-ALF with or without (as control) supplemented human recombinant SP-D (5 μg/mL, R&D Systems). After exposure ...
-
bioRxiv - Immunology 2023Quote: ... recombinant human PD-L1 human IgG1 Fc chimera protein (R&D Systems), or mouse IgG1 isotype antibodies (R&D Systems ...
-
bioRxiv - Biophysics 2021Quote: ... Recombinant Human EGF Protein (R&D Systems). Erlotinib hydrochloride (500nM ...
-
bioRxiv - Biochemistry 2019Quote: ... Human recombinant EGF protein (R&D Systems) was diluted to 10x in serum free medium ...
-
PVT1, a YAP1 dependent stress responsive lncRNA drives ovarian cancer metastasis and chemoresistancebioRxiv - Cancer Biology 2022Quote: ... epithelial to mesenchymal transition (EMT) was induced with 200 pM of Human recombinant TGF-beta 1 (R&D Systems, 240-B); verteporfin (Sigma Aldrich ...
-
bioRxiv - Cancer Biology 2021Quote: ... Luciferase activity was confirmed using recombinant human TGFβ (R&D Systems, #240-B-010) treatment.
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL human basic fibroblast growth factor (b-FGF) (R&D Systems, Inc.), and 10 μM Y27632 (FUJIFILM Wako Pure Chemical Corporation ...
-
bioRxiv - Molecular Biology 2023Quote: The recombinant human transforming growth factor beta (TGFβ) protein and recombinant human TSP2 protein were obtained from R&D Systems. The SMAD3 Inhibitor SIS3 was procured from Cayman Chemical Company ...
-
bioRxiv - Cell Biology 2024Quote: Human colonic organoids were treated with recombinant human IL-22 protein (R&D Systems) at 10 ng/mL ...
-
bioRxiv - Genomics 2021Quote: ... Isolated B cells were cultured in IMDM medium supplemented with 10% FBS and 55 mM beta-mercaptoethanol at 1X106 cell/mL and activated by CellXVivo Human B cell expander (1:250 dilution, R&D system) and 50 ng/mL IL2 (Cat#200-02-10ug ...
-
bioRxiv - Bioengineering 2021Quote: ... and 100 U/mL Penicillin/Streptomycin supplemented with 0.1% recombinant human Fetal Growth Factor b (Alamone F-170) and 0.1% recombinant human Epidermal Growth Factor (R&D systems 236-EG). On Day 12 ...
-
bioRxiv - Cell Biology 2023Quote: Primary human lung fibroblasts (passages 3-9) were exposed to 5ng/ml recombinant human TGF-β1 (R&D Systems, 240-B-002), 180μM H2O2 (Sigma ...
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were treated with 5 ng/mL recombinant human TGFβ1 (R&D Systems, 240-B) prepared according to the manufacture’s specifications ...
-
bioRxiv - Cell Biology 2022Quote: Same amount (1 μM) of purchased Human IMPDH2 recombinant protein (8349-DH-050, R&D systems) was incubated in 50 mM HEPES buffer (pH 8.5 ...
-
bioRxiv - Cancer Biology 2024Quote: ... samples were treated with recombinant human PD-1 Fc protein (1086-PD-050, R&D System) at 4 °C overnight ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... Human 26S Proteasome Protein (E-365) and Human 20S Proteasome Protein (E-360) were purchased from R&D Systems (Minneapolis, MN, USA). Human KRAS (G12D ...
-
bioRxiv - Cell Biology 2020Quote: ... 500ng/ml Recombinant Human Noggin Protein (R&D Systems) and 10μM SB431542 (Tocris ...
-
bioRxiv - Cancer Biology 2022Quote: Human Fibronectin Protein (1918-FN-02M, R&D Systems), Fibronectin bovine plasma (F1141 ...
-
bioRxiv - Molecular Biology 2021Quote: ... and recombinant human angiogenin protein (R&D Systems, USA) at concentrations of 0.1μM ...
-
bioRxiv - Synthetic Biology 2022Quote: ... Recombinant human interferon (rhIFN) proteins from R&D systems (IFN-β [Cat# 8499-IF-010/CF] ...
-
bioRxiv - Cancer Biology 2023Quote: ... and carrier-free human CXCL12 protein (R&D systems) at 1:1 molar ratio and the mixture was incubated at room temperature for 2 hours ...